| Literature DB >> 26458990 |
Cao De Hong1, Liu Liang Ren1, Wei Qiang1, Wang Jia1, Hu Ying Chun2, Yang Lu1, Liu Zheng Hua1, Li Heng Ping1,3, Yan Shi Bing1, Li Yun Xiang1.
Abstract
Worldwide, prostate cancer (PCa) is the second most common malignancy in males. We undertook a meta-analysis to compare the efficacy and safety of conventional laparoscopic radical prostatectomy with a transperitoneal (TLRP) approach, versus that of an extraperitoneal (ELRP) approach, for treatment of localized PCa. A comprehensive literature search retrieved 14 publications, with a total of 1715 patients. Meta-analysis of these studies showed that an ELRP approach was associated with a significantly shorter postoperative catheterization time (MD: 1.99; 95% CI: 0.52 to 3.54; P = 0.008), less blood transfusion rate (OR: 2.05; 95% CI: 1.03 to 4.06; P = 0.04), shorter intestinal function recovery time (MD: 0.08; 95% CI: 0.52 to 1.09; P < 0.0001) and shorter hospitalization days (MD: 2.71; 95% CI: 1.03 to 4.39; P = 0.002). In addition, our results showed no statistically significant differences between the two groups in operation time (MD: 19.39; 95% CI: -6.67 to 45.44; P = 0.014), intraoperative blood loss (MD: 4.89; 95% CI: -105.00 to 114.79; P = 0.93) and total complication rate (RR: 1.22; 95% CI: 0.86 to 1.74; P = 0.27). In summary, our meta-analysis showed that ELRP is likely to be a safe and feasible alternative for localized PCa patients compared with TLRP.Entities:
Mesh:
Year: 2015 PMID: 26458990 PMCID: PMC4602188 DOI: 10.1038/srep14442
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram of evidence acquisition.
Basic features and quality assessments of the included studies.
| Study, year | Studydesign | Origincountry | TLRP/ELRP | Qualitylevels | |||
|---|---|---|---|---|---|---|---|
| No. ofPatients | Mean age (range) (years) | Mean PSA (ng/mL) | Mean Gleason score | ||||
| Eden,2004 | CCT | England | 100/100 | 62.3(52–72)/61.4(45–73) | 7.7(2.0–27.0)/7.6(1.0–19.0) | 5.9(4.0–8.0)/6.1(4.0–9.0) | high |
| Cathelineau,2004 | CCT | France | 100/100 | 63(49–76)/61 (48–75) | 8.9 ± 4.7/10.0 ± 8.0 | NA | high |
| Ruiz,2004 | CCT | France | 165/165 | 64.1 ± 6.4/62.9 ± 6.8 | 10.8 ± 9.2/9.9 ± 8.7 | 5.7 ± 1.2/6.2 ± 1.0 | high |
| Erdogru,2004 | CCT | Germany | 53/53 | 62.9 ± 5.4/62.9 ± 5.5 | 7.6 ± 3.8/7.4 ± 4.6 | 6.1 ± 0.8/6.0 ± 0.7 | high |
| Remzi,2005 | CCT | Austria | 39/41 | 61.0 ± 11.0/59.0 ± 12.0 | 5.5 ± 3.7/8.1 ± 6.1 | 5.1 ± 1.2/5.5 ± 1.3 | high |
| Brown,2005 | CCT | America | 122/34 | 58/56 | NA | NA | high |
| Porpiglia,2006 | CCT | Italy | 80/80 | 64.2 ± 5.1/64.4 ± 5.9 | 8.3 ± 4.3/9.7 ± 5.7 | NA | high |
| Katz,2006 | CCT | France | 22/13 | 67.5 ± 4.4/67.5 ± 4.4 | NA | NA | high |
| Gao,2006 | CCT | China | 12/19 | 62.6 ± 6.7/63.1 ± 7.7 | 9.7 ± 3.1/8.8 ± 1.8 | NA | high |
| Wang,2008 | CCT | China | 21/12 | 66(46–74)/66(56–73) | 28.9(9–120)/32.2(5–130) | 6.6(5.0–9.0)/7.0(6.0–9.0) | high |
| Siqueira,2010 | CCT | Brazil | 40/40 | 59.8 ± 6.8/63.6 ± 7.9 | 5.4 ± 2.0/5.9 ± 1.9 | NA | high |
| Wang,2010 | CCT | China | 39/15 | 68.1 ± 5.2/68.3 ± 6.1 | 15.4 ± 4.2/14.1 ± 6.3 | 7.4 ± 0.8/7.2 ± 0.7 | high |
| San,2012 | CCT | China | 30/30 | 65.8(45–73)/66.1(42–70) | 36.2(5–130)/ 36.2(5–130) | 7.0(6.0–9.0)/7.0(6.0–9.0) | high |
| Zhao,2014 | CCT | China | 116/74 | 66.8(50–78)/ 66.8(50–78) | 11.13(1.13–28.35)/11.13(1.13–28.35) | NA | high |
TLRP = transperitoneal laparoscopic radical prostatectomy; ELRP=extraperitoneal laparoscopic radical prostatectomy; PSA = prostate specific antigen; NA = not applicable; CCT = clinical controlled trial.
Figure 2Forest plot of operation time between TLRP and ELRP group.
Figure 3Forest plot of intraoperative blood loss between TLRP and ELRP group.
Figure 4Forest plot of blood transfusion rate between TLRP and ELRP group.
Figure 5Forest plot of postoperative catheterization time between TLRP and ELRP group.
Figure 6Forest plot of postoperative intestinal function recovery time between TLRP and ELRP group.
Figure 7Forest plot of hospitalization days between TLRP and ELRP group.
Figure 8Forest plot of total complication rate between TLRP and ELRP group.